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Polarized expression of the vasopressin V2 receptor in Madin- nus, and appears to be exclusively expressed in the princi-
Darby canine kidney cells. pal cell of the renal collecting duct [1]. Immunohistologi-
Background. The vasopressin V2 receptor is expressed in cal studies of rat kidney revealed that the V2 receptorthe polarized principal cell of the renal collecting duct. Inacti-
is predominantly localized in the basolateral and, to avating mutations of the vasopressin V2 receptor gene cause
small extent, apical membrane of principal cells [2]. Acti-X-linked nephrogenic diabetes insipidus (NDI). Most of the
mutant V2 receptors show transport defects, as analyzed in vation of the receptor by 8-arginine vasopressin (AVP)
non-polarized cells, but data pertaining to polarized cells have leads to stimulation of adenylyl cyclase via Gs. The in-not previously been presented. crease of cAMP and the subsequent activation of proteinMethods. Madin-Darby canine kidney cell (MDCK) II clones
kinase A induce the insertion of intracellularly storedstably expressing c-myc–tagged human V2 receptors were char-
water channels (aquaporin-2) into the apical membraneacterized for [3H]-arginine vasopressin (AVP)-binding and
AVP-sensitive adenylyl cyclase activity. The V2 receptors were of the principal cells. As a consequence, the water perme-
immunocytochemically localized using the tyramide signal am- ability of the apical membrane is dramatically increased,
plification technique in conjunction with an anti–c-myc antibody.
facilitating the reabsorption of water (antidiuretic effect)Results. The introduction of the c-myc epitope at the N- or
from the hypotonic urine in the collecting duct.C-terminus did not affect the functional properties of the V2
receptor expressed in MDCK II clones. However, the use of In nephrogenic diabetes insipidus (NDI), the kidney
standard immunofluorescence methodology for these MDCK fails to concentrate urine despite normal or even ele-
II clones yielded only weak signals. With the tyramide signal vated levels of AVP. Inactivating mutations of the V2
amplification technique, strong signals were obtained, showing
receptor gene have been identified as the cause ofthe V2 receptor to be mainly localized within the lateral and,
X-linked NDI, whereas inactivating mutations of theto a minor extent, apical membrane. In MDCK II clones stably
expressing the c-myc–tagged V2 receptor NDI mutant L44P, aquaporin-2 gene lead to autosomal-recessive NDI [re-
fluorescent signals were found exclusively within the cell. viewed in 3–5]. The functional characterization of V2
Conclusion. The wild-type V2 receptor is expressed mainly in receptor mutants has revealed three different types ofthe lateral membrane, whereas the L44P mutant is completely
molecular defects that lead to loss of function: (a) defectsretained within the cell. In conjunction with tyramide signal
in the transport of the receptor to the plasma membrane,amplification, MDCK II cells constitute a suitable model for
the analysis of transport-defective mutants of the V2 receptor. (b) defects in ligand binding, and (c) defects in G-protein
coupling and activation [6]. Most of the mutants analyzed
exhibit a transport defect. Functional analysis has hith-
The vasopressin V2 receptor (V2 receptor) belongs to erto been performed in only non-polarized cell systems.
the large family of G protein–coupled receptors charac- Because kidney tissue from patients suffering from
terized by a heptahelical transmembrane organization, X-linked NDI is not available, the consequences of intra-
an extracellular N-terminus, and an intracellular C-termi- cellular transport defects in the polarized principal cell
are not amenable to direct investigation. Therefore, we
established an expression system for the V2 receptor in
Key words: MDCK, nephrogenic diabetes insipidus, vasopressin V2
Madin-Darby canine kidney (MDCK) II cells, a polar-receptor, c-myc tag, tyramide signal amplification, transport defective
mutant. ized cell line derived from the canine renal collecting
duct [7]. A c-myc epitope was engineered at the N- orReceived for publication September 24, 1998
C-terminus of the human V2 receptor to facilitate detec-and in revised form March 10, 1999
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wild-type V2 receptor was detected predominantly in medium was supplemented with geniticin 418 (400 mg/ml;
GIBCO BRL, Eggenstein, Germany).the lateral membranes of polarized MDCK II cells. The
L44P mutant was exclusively found intracellularly, in
Stable expression of wild-type and mutant V2agreement with recent data showing the mutant to be
receptors in Madin-Darby canine kidney II cellsretained within the endoplasmic reticulum [9]. MDCK
Stable transfection of MDCK II cells was performedII cells therefore represent a suitable expression system
as recently described [11]. In brief, 200,000 cells perto analyze the transport defects of mutant V2 receptors
60 mm Petri dish were transfected overnight with a mix-occurring in families with X-linked NDI.
ture of Lipofectin (GIBCO BRL, Eggenstein, Germany)
and plasmid DNA in serum-free DMEM according to
METHODS the manufacturer’s protocol. Cells were incubated in
DNA manipulation complete medium (3 days), and geniticin was then added
for selection. Seven days after transfection, cells wereStandard DNA manipulations were carried out ac-
harvested, and serial dilutions were made. After four tocording to the handbook of Sambrook, Fritsch, and Ma-
seven days, individual clones were selected, cultivated,niatis [10]. Automated sequencing of DNA fragments
and tested for ligand binding.was performed using the ABI PRISM Dye Terminator
Cycle Sequencing kit (Amplitaq DNA Polymerase FS; Transient expression of V2 receptors in COS.M6 cells
Perkin Elmer, Langen, Germany) on the Applied Bio-
Transfection of COS.M6 cells was carried out as de-systems 373A DNA Sequencer (Weiterstadt, Germany).
scribed previously [9]. Control cells were mock trans-
fected with pcDNAI/Neo (Invitrogen).Construction of c-myc epitope-tagged receptors
The V2 receptor cDNA was cloned from plasmid pRCD [3H]AVP binding assay to intact cells and membranes
N2 [11] into M13 mp19 (Pharmacia, Freiburg, Germany) of Madin-Darby canine kidney II clones
as a BamHI/XbaI fragment. A c-myc epitope (EQKLI- and Scatchard analysis
SEEDL, residues 408 to 439 of c-myc) was inserted by
Binding of [3H]AVP to intact MDCK cells was per-site-directed mutagenesis either between methionine 3
formed as described [11]. Unspecific binding, determined
and alanine 4 in the N-terminus or between serine 371
in the presence of a 100- to 1000-fold excess of unlabeled
and the stop-codon at the C-terminus of the V2 receptor
AVP, was less than 10% of total binding. Binding of
cDNA. Site-directed mutagenesis was carried out with [3H]AVP to membranes of MDCK cells was performed
the Sculptor in vitro Mutagenesis System (Amersham, as described [12]. 8-Arginine vasopressin (AVP) and the
Braunschweig, Germany). The oligonucleotides were V2-selective agonist 1-deamino-cys-8-D-arginine vaso-
59CCCCACC ATG CTC ATG GAA CAA AAG CTT pressin (dDAVP, desmopressin) were purchased from
ATT TCT GAA GAA GAC TTG GCC TCC ACC Sigma-Aldrich (Deisenhofen, Germany). The V2-selec-
ACT TCC GCT GTG 39 (N-tag) and 59CTG GCC AAG tive antagonist SR 121463A [13] was kindly provided by
GAC ACT TCA TCG GAA CAA AAG CTT ATT Claudine Serradeil-Le Gal, Sanofi Recherche, Toulouse,
TCT GAA GAA GAC TTG TGAGGATCTTCTA- France.
GAGGGCCC 39(C-tag). The mutant cDNAs were cloned
as BamHI/XbaI fragments into the eukaryotic expression Isolation of RNA from Madin-Darby canine
vector pCDNAI.Neo (Invitrogen, Leek, The Netherlands), kidney cell II clones and Northern blots
yielding plasmids encoding the N-tagged (pNV2Rmyc) Total RNA was isolated from MDCK II clones with
and C-tagged (pCV2Rmyc) V2 receptor, respectively. the RNAzole B kit (WAK-Chemie Medical GmbH, Bad
The L44P mutant [9] was cloned as an NdeI/PmlI frag- Homburg, Germany). Size separation of total RNA (20
ment into the NdeI/PmlI cut plasmid pCV2Rmyc. Muta- mg) on 1.1% agarose gels containing 2.2 m formaldehyde
genesis was verified by sequencing. was followed by capillary transfer onto nylon membranes
(Qiagen, Hilden, Germany) and ultraviolet cross-linking
Cell culture (2 3 90 seconds at 312 nm). Prehybridization and hybrid-
Madin-Darby canine kidney II cells and COS.M6 cells ization with random primed full-length V2 receptor
were generously donated by K. Simons (EMBL, Heidel- cDNA (2.5 3 106 cpm/ml; Prime It Kit; Stratagene, Hei-
berg, Germany) and F. Fahrenholz (Frankfurt, Ger- delberg, Germany) was performed in Quick-Hybt solu-
many), respectively. The cells were cultured at 5% CO2 tion (Stratagene) at 608C for one hour. Membranes were
in Dulbecco’s modified Eagle’s medium (DMEM) con- washed at increasing stringency with a final wash in
taining 10% (vol/vol) heat-inactivated fetal bovine serum, 0.25 3 sodium salt citrate (SSC)/0.1% sodium dodecyl
penicillin (100 units/ml), and streptomycin (100 mg/ml). sulfate (SDS) at 508C for 15 minutes. The membranes
were exposed to Kodak X-Omat AR films for 12 hours.For cultivation of stably transfected MDCK II cells, the
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Adenylyl cyclase assay with PBS. The cover slips were incubated with 30 ml
biotin-SP–conjugated AffiniPure F(ab9)2 fragment goatThe preparation of nuclei-free crude membrane frac-
antirabbit IgG (H 1 L; 1:500 in PBS; Dianova) for onetions from MDCK II clones and the adenylyl cyclase
hour at 378C. A modified protocol for tyramide signalassay were performed as described previously [14], with
amplification (TSA-Direct Green; NEN, Ko¨ln, Ger-the exception that 1.5 mm MgCl2 and 1 mm ethylenedi-
many) was subsequently followed. The cover slips wereaminetetraacetic acid (EDTA) were present in the reac-
incubated with 30 ml of streptavidin-horseradish peroxi-tion mixture. [32P]cAMP was isolated by the two-column
dase conjugate (1:2000) and fluorescein tyramide (1:200)method [15].
and mounted with 50% glycerol in PBS containing 100
mg/ml 1,4-diazabicyclo [2.2.2]octane (DABCO; Sigma,Antibodies
Mu¨nchen, Germany). The cover slips were sealed withMonoclonal anti–c-myc antibody (clone 9E10) was
nail polish. At least three independent preparations werepurchased from Dianova (Hamburg, Germany). Poly-
analyzed with a Zeiss LSM410 inverted laser scanningclonal anti–c-myc antibody was raised against a synthetic
microscope or with a Zeiss Axiophot epifluorescencepeptide corresponding to the c-myc fragment EQKLI-
microscope (Carl Zeiss, Jena, Germany). RepresentativeSEEDL coupled through an extra C-terminal tyrosine
pictures were taken with the camera system Sony 3CCDto the carrier protein keyhole limpet hemocyanin (KLH;
on Kodak T-MAX400. The controls consisted of (a)Calbiochem, Bad Soden, Germany) [16]. The titer of the
clones expressing V2 receptor without the c-myc tag,antiserum was determined by enzyme-linked immuno-
(b) incubation without a primary antibody, or (c) nosorbent assay, and its specificity was verified by immu-
amplification reagent (fluorescein tyramide).noblotting. Polyclonal anti–c-myc antibody was purified
Cells grown on filters. Five 3 105 cells were grown onwith protein G-Sepharose 4 Fast Flow (Pharmacia, Frei-
permeable polycarbonate filter supports (24 mm diame-burg, Germany) according to the manufacturer’s proto-
ter Transwell permeable supports, 0.4 mm pore polycar-col. The eluted IgG fraction was dialyzed against phos-
bonate membrane; Costar, Bodenheim, Germany) forphate-buffered saline (PBS) and stored at 2208C.
four days. After fixation and permeabilization (discussed
earlier in this article) the filters were cut into two toImmunoblots
three pieces (approximately 5 mm square and marked at
The preparation of membranes from COS.M6 clones one edge) and transferred onto Parafilm in a humidifying
and immunoblotting was performed as described pre- chamber. Each filter piece was incubated with 50 ml 5%
viously [9]. Nitrocellulose membranes were incubated unspecific goat serum on both sides for 20 minutes at
with either monoclonal or polyclonal anti–c-myc anti- 378C, washed with PBS, and incubated with purified
body. As secondary antibody, either horseradish peroxi- polyclonal anti–c-myc antibody (1:130) overnight at 48C.
dase-conjugated antirabbit IgG or 125I-labeled antirabbit Filters were washed in the wells of the cell culture plates.
and antimouse IgG were used. The washed filters were Subsequent incubation steps were as described earlier
visualized with 4-chloro-1-naphthol and H2O2 or were in this article. The filters were mounted on two plastic
exposed to Kodak X-Omat AR films for two to five days. spacers on a slide with the cells facing up. A cover slip was
placed above the filter and sealed with nail polish [17].Immunocytochemistry with anti–c-myc antibody
Cells grown on glass cover slips. Five 3 105 cells were Immunocytochemistry with anti–ZO-1 antibody
seeded in a 35-mm diameter dish containing four cover For ZO-1 localization, the conventional immunostain-
slips and cultured for four days to confluence. Cells were ing procedure with rat polyclonal anti–ZO-1 antibody
washed twice with PBS (137 mm NaCl, 2.7 mm KCl, 10.1 (1:200 in PBS; DPC Biermann, Bad Nauheim, Germany)
mm Na2HPO4, 1.1 mm KH2PO4, pH 7.4), fixed with freshly and TRITC-conjugated sheep antirat IgG (1:200 in PBS;
made 3% paraformaldehyde in PBS for 10 minutes at Dianova) was followed. Permeabilization and processing
room temperature, and washed three times with PBS. for laser scanning microscopy was as described earlier
The cover slips were transferred to a humidifying cham- in this article.
ber. For permeabilization, cells were incubated in PBS
containing 0.1% Triton X-100 for five minutes and
RESULTSwashed three times with PBS prior to transfer. Unspecific
Immunoblot analysis of COS.M6 cells expressingbinding was blocked with 5% normal goat serum (Dia-
c-myc–tagged wild-type V2 receptornova) for 20 minutes at 378C, followed by three rinses
for 5 minutes with PBS. Cover slips were incubated for C- or N-terminally c-myc–tagged V2 receptors were
one hour at 378C or overnight at 48C with 25 ml protein expressed transiently in COS.M6 cells, and membrane
G-Sepharose–purified polyclonal anti–c-myc antibody preparations of these cells were analyzed by Western
blotting. Incubation with polyclonal anti–c-myc antibody(1:160 in PBS) and washed three times for 10 minutes
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Fig. 1. Immunoblot analysis of c-myc–tagged V2 receptor with anti–c-myc antibody. Membrane preparations (60 mg protein) from COS.M6 cells
transfected with cDNA encoding c-myc–tagged V2 receptor were separated on 12% sodium dodecyl sulfate-polyacrylamide gels, transferred onto
nitrocellulose filters and incubated with polyclonal rabbit anti–c-myc antibody or monoclonal mouse anti–c-myc antibody. Specific binding was
detected with peroxidase-conjugated antirabbit IgG (A–C) or with [125I]-labeled antimouse IgG (D). (A) Incubation with rabbit preimmune serum
(1:500). (B) Incubation with polyclonal anti–c-myc antibody (1:500). (C) Incubation with polyclonal anti–c-myc antibody as in (B) but serum
preincubated with c-myc peptide (3.5 mm). (D) Incubation with monoclonal anti–c-myc antibody (2.5 mg/ml). Mock, vector without V2 receptor
cDNA. C-tag, vector with C-terminal–tagged V2 receptor cDNA. N-tag, vector with N-terminal–tagged V2 receptor cDNA. Similar results were
obtained in at least two independent experiments.
resulted in immunoreactive signals of apparent molecu- (which takes place 19 amino acids C-terminal of the
c-myc epitope) might mask the c-myc epitope from thelar masses of 37, 40, and 75 to 85 kDa and multiple bands
in the region of 45 to 60 kDa (Fig. 1B). The immunoreac- antibody. In membrane preparations of MDCK II clones
expressing the c-myc–tagged V2 receptor, we failed totive band migrating at 40 kDa was presumed to be unspe-
detect any specific signal in immunoblot experiments.cific, as it was also found in mock-transfected cells (Fig.
1A). The specificity of the polyclonal anti–c-myc anti-
[3H]AVP binding and adenylyl cyclase activitybody was verified by peptide competition. Preincubation
of the polyclonal anti–c-myc antibody with c-myc peptide To study the functional properties of MDCK II clones
stably expressing c-myc–tagged V2 receptor, intact cellsabolished the immunoreactivity with the exception of
the band migrating at 40 kDa (Fig. 1C). The results were assayed for specific [3H]AVP binding, and mem-
brane preparations were analyzed for adenylyl cyclaseobtained with the polyclonal anti–c-myc antibody were
confirmed with the monoclonal anti–c-myc antibody activity. Saturation binding and Scatchard analyses re-
vealed similar KD values for the cells expressing moder-(Fig. 1D). The intensities observed, especially in the case
of the 75 to 85 kDa band, were variable in each experi- ate (up to 200,000 sites/cell) or high levels (.300,000
sites/cell) of the wild-type or c-myc–tagged V2 receptorsment. These differences did not correlate with the posi-
tion of the c-myc epitope in the V2 receptor but varied (Table 1). The EC50 values ranged between 2 and 10
nm for the different cell clones and did not reveal anybetween the transfection experiments. The 37 kDa band
most likely represents the immature V2 receptor, and influence of the tag at either the N- or C-terminus. Mem-
brane preparations of untransfected MDCK II cellsthe broad band migrating at 75 to 85 kDa dimers of the
same, as suggested by the work of Sadehgi, Innamorati, showed neither significant [3H]AVP binding nor AVP-
induced stimulation of adenylyl cyclase activity, sug-and Birnbaumer [18]. Interestingly, the bands in the re-
gion of 45 to 60 kDa were easily visualized in the case gesting the absence of endogenous V2 receptors, in con-
trast to the data of Scho¨neberg et al [19] and Deen etof the C-terminally tagged receptor but were hardly de-
tectable for the N-terminally tagged receptor. Thus, the al [20]. This discrepancy may arise from the different
MDCK clones used. We also established MDCK IIc-myc epitope might be thought to impair glycosylation
of the V2 receptor, or alternatively, the glycosylation clones expressing the L44P mutant V2 receptor. Because
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Table 1. [3H]AVP binding and adenylyl cyclase activity of MDCK II clones stably expressing the wild-type or c-myc V2 receptor
[3H]AVP binding
Adenylyl cyclase activity
Basal PGE1 100 mm AVP 10 mm
pmol cAMP/mg EC50 for AVP
MDCK II clone KD nm Sites/cell protein/min nm
Clones with moderate levels of V2 receptor
Wild-type (V2RWT A4) 3.4 189,000 9.4 27.6 27.3 3.2
N-terminal tagged (NV2R B5) 2.5 177,000 3.6 25.9 25.3 2.3
C-terminal tagged (CV2R A5) 4.1 156,000 3.4 27.5 25.8 3.5
Clones with high levels of V2 receptor
Wild-type (V2RWT A2) 3.2 302,000 6.5 16.0 21.1 2.9
N-terminal tagged (NV2R B4) 3.9 940,000 3.9 9.8 8.7 9.5
C-terminal tagged (CV2R A1) 3.6 431,000 6.4 19.6 19.0 6.4
Stable MDCK II clones expressing wild-type or c-myc tagged V2 receptor were tested for [3H]AVP binding to intact cells and adenylyl cyclase assays as described
in the Methods section. These clones were used for immunocytochemistry. KD values were calculated from saturation experiments (specific binding of [3H]AVP to
intact cells). Data represent mean values of duplicates, which differed by less than 10%. Similar results were obtained in at least two independent experiments. EC50
values are the AVP concentrations required for half-maximal activation of adenylyl cyclase in crude membrane fractions. AVP was assayed at concentrations from
30 pm to 10 mm. Data represent mean values of duplicates, which differed by less than 10%. Similar results were obtained in at least three independent experiments.
Fig. 2. Northern blot analysis of Madin-Darby canine kidney (MDCK) CL44P.myc clones. Total RNA isolated from MDCK II clones stably
transfected with the L44P mutant V2 receptor cDNA were screened in Northern blot analysis (20 mg/lane) for specific V2 receptor transcripts.
The blots were hybridized with radiolabeled V2 receptor cDNA as described in the Methods section. At the top, the code of the individual MDCK
CL44P.myc clones is indicated. Left, size standards. Right, specific message. V2R is vasopressin V2 receptor mRNA.
this mutation was recently shown to display no significant applying the direct tyramide signal amplification (TSA)
binding [9], the individual clones were screened for spe- technique [8], we were able, however, to detect V2 recep-
cific transcripts by Northern blot analysis (Fig. 2). MDCK tors in MDCK II clones. The cells were incubated with
clones displaying abundant specific transcripts of the ex- protein G-Sepharose–purified polyclonal anti–c-myc anti-
pected size of approximately 1.8 kb were investigated body, followed by biotinylated secondary antibody. After
using the tyramide signal amplification technique (clones binding of streptavidin/horseradish peroxidase complex
A3, A4, C1, and C3). In membrane preparations of these to biotin, the peroxidase catalyzes the formation of fluo-
clones, we failed to detect significant [3H]AVP binding rescein tyramide radicals in the presence of hydrogen
(Fig. 3), thereby confirming the data previously found peroxide. The radicals react with proteins in the immedi-
for the L44P mutant expressed in COS.M6 cells [9]. ate vicinity of the enzyme, hence immobilizing fluores-
cein tyramide at the site of immunoreactivity. The poly-
Immunocytochemical localization clonal antibody yielded more intense signals than the
monoclonal antibody 9E10 (not shown). Staining of per-Conventional immunostaining of MDCK II clones ex-
meabilized, confluent MDCK II clones expressing thepressing the c-myc–tagged V2 receptor with anti–c-myc
C- or N-terminally tagged V2 receptors resulted in aprimary antibody and Cy3-coupled secondary antibody
honeycomb pattern, which is typical for proteins ex-failed to give signals of sufficient intensity for analysis
pressed in the lateral membranes of polarized cells (Fig.by either epifluorescence or laser scanning microscopy,
4 B, C). The C-terminally tagged V2 receptor was detect-in sharp contrast to COS.M6 cells transiently expressing
the N- or C-terminally tagged V2 receptor [12]. By able only in permeabilized cells (Fig. 4C), whereas the
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The separation of apical and basolateral subdomains
is physically maintained by tight junctions. To exclude
the possibility that the apical signal of the V2 receptor
might be caused by incomplete polarization, we analyzed
confluent MDCK II clones with anti–ZO-1 antibody for
the presence of tight junctions. ZO-1, a 225-kDa poly-
peptide, is localized exclusively on the cytoplasmic face
of the tight junctions in a variety of epithelia [23]. Figure
6 shows the horizontal (xy-scan, upper panel) and verti-
cal sections (xz-scan, lower panel) of MDCK II clones
grown on cover slips. The basal surface of the cells corre-
sponds to the top of the xz-scan. A defined region of the
lateral membranes close to the apical surface was stained
Fig. 3. [3H]AVP-binding to membrane preparations from Madin- strongly (compare lower panels of Fig. 6 and Fig. 5C),
Darby canine kidney (MDCK) II clones. Stable MDCK II clones ex- thereby confirming the integrity of the tight junctions.pressing either c-myc epitope-tagged V2 receptor (NV2R B5) or the
We also investigated V2 receptor localization in precon-L44P mutant V2 receptor (CL44 PV2R C3) were tested for [3H]AVP
binding to membrane preparations as described in the Methods section. fluent MDCK II clones. In such subconfluent cultures
Binding was performed with 10 nm [3H]AVP in the presence or absence (in which cells are not yet tightly associated), stainingof 1 mm unlabeled agonist AVP, 1 mm V2-selective agonist dDAVP
of the V2 receptor was homogeneous over the whole(desmopressin), and 10 mm V2-selective antagonist SR 121463A, respec-
tively. The data represent triplicates 6 sd. Similar results were obtained membrane, indicating no polarized localization (asterisk,
in two independent experiments. Symbols are: (j) [3H]AVP; (h) Fig. 7). When adjacent cells formed cell–cell contacts, a[3H]AVP/1 mm AVP; ( ) [3H]AVP/1 mm dDAVP; ( ) [3H]AVP/10
strong staining in the plasma membrane between themm SR 121463A.
cells was detectable, even before the cell layer became
completely confluent (arrow ←, Fig. 7).
The L44P mutant V2 receptor has been identified in
N-terminally tagged V2 receptor was visible in both per- a family with X-linked NDI [24]. Functional character-
meabilized (Fig. 4B) and unpermeabilized cells (Fig. 5A, ization of the L44P mutant receptor in non-polarized
upper panel). The signals obtained with cells expressing COS.M6 and Ltk2 cells demonstrated that this mutant
the C-terminally tagged V2 receptor were stronger than is retained within the endoplasmic reticulum [9]. To dem-
from those expressing N-terminally tagged V2 receptors. onstrate that the L44P mutant V2 receptor is also
This result is in agreement with the immunoblot analysis trapped within a polarized cell, we used the TSA tech-
showing weaker staining of the glycosylated bands of nique. Confluent monolayers of MDCK II clones stably
the N-terminally tagged V2 receptor compared with the expressing the L44P mutant receptor showed immuno-
C-terminally tagged V2 receptor. reactivity within the cells, but not at the membrane
Various membrane proteins are transported preferen- (Fig. 4D). In contrast to the wild-type receptor (Fig. 4C),
tially to either the apical or basolateral plasma mem- staining of the L44P mutant did not result in the typical
brane. For example, the adenosine A1 receptor [21] is honeycomb pattern. In conjunction with a lack of specific
almost exclusively found in the apical membrane of po- [3H]AVP binding to membrane preparations of MDCK
larized cells and the a2A-adrenergic receptor in the baso- clones stably expressing the L44P mutant receptor, the
lateral membrane [22]. We investigated the distribution data indicate that the transport defect is also manifested
of the c-myc–tagged V2 receptor in the subdomains of in a polarized cell.
the plasma membrane of stably transfected MDCK II
clones by laser scanning microscopy. Vertical sections
DISCUSSIONof MDCK II clones revealed strong lateral staining (Fig.
5, lower panel). In addition to the lateral staining, faint We established MDCK II clones stably expressing epi-
tope-tagged V2 receptors for immunocytochemical anal-staining of the apical membrane was visible. No basal
staining was detectable in permeabilized cells grown on ysis of polarized receptor expression. The functional
properties (KD, EC50, Bmax) of the c-myc–tagged (at theglass cover slips (Fig. 5 B, C, lower panel). To exclude
the possibility that the antibodies added to the apical N- or C-terminus) wild-type V2 receptor expressed in
MDCK II clones were the same as those of the untaggedside of the cells grown on cover slips might fail to reach
the receptors on the basal surface, the cells were grown V2 receptor (Table 1). Similar results have been reported
for N- or C-terminally HA-tagged V2 receptors (harbor-on permeable filter supports. The addition of antibodies
to both sides of the filter (corresponding to the basal ing a peptide derived from influenza hemagglutinin pro-
tein as epitope) expressed in non-polarized COS.M6,and apical sides of the cell layer) did not result in staining
of the basal membrane (Fig. 5A). HEK293, or CHO-cells [6, 25, 26], and a polyoma virus
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Fig. 4. Localization of the c-myc–tagged wild-type V2 receptor in confluent Madin-Darby canine kidney (MDCK) II clones. MDCK II clones
were grown on glass cover slips, fixed, permeabilized, and processed with anti–c-myc antibody for epifluorescence microscopy. (A) V2 receptor
without c-myc tag (302,000 sites per cell). (B) N-tagged V2 receptor (177,000 sites per cell). (C) C-tagged V2 receptor (156,000 sites per cell). (D)
C-tagged L44P mutant of V2 receptor. Bar 10 mm.
medium T antigen epitope-tagged V2 receptor expressed N-terminally HA–tagged V2 receptor yielded bands ex-
clusively at 40 and 75 kDa, whereas immunoprecipitationin COS-7 cells [27]. Interestingly, immunoblot analysis
with anti–c-myc antibodies of membranes derived from of membranes of the same CHO clones after cell surface
iodination yielded only a single band of approximatelyCOS.M6 cells expressing either the C- or the N-terminally
c-myc–tagged V2 receptor displayed prominent bands 55 kDa. It was suggested that only the 55 kDa band
represents the glycosylated V2 receptor localized at theat approximately 37 and 75 to 85 kDa, which most likely
represent the monomeric and dimeric immature V2 re- cell surface [6]. In these experiments, the N-terminally
fully glycosylated HA-tagged V2 receptor was obviouslyceptor, respectively (Fig. 1 B, D) [18]. Multiple bands
of 45 to 60 kDa were easily detected, however, only in also less efficiently recognized than the monomeric and
dimeric immature receptors at 40 and 75 kDa.membrane preparations of COS.M6 cells expressing the
C-terminally tagged V2 receptor (Fig. 1 B, D). These In transiently transfected COS.M6 cells, c-myc–tagged
V2 receptors were easily detectable by conventional im-bands appear to represent the glycosylated V2 receptor.
Sadeghi, Innamorati, and Birnbaumer also found bands munocytochemistry. Saturation analysis of [3H]AVP
binding to intact COS.M6 cells revealed on averageat 45 to 55 kDa, which were assigned as the complex
glycosylated V2 receptor [18]. Thus, it appears either that about 200,000 receptors per cell, that is, comparable to
the MDCK II clones. However, considering that onlyglycosylation of the V2 receptor masks the N-terminally
fused c-myc epitope or, alternatively, that the c-myc epi- approximately 5 to 10% of the transiently transfected
cells showed high levels of expression, it is obvious thattope might hamper glycosylation. The former notion is
supported by the work of Tsukaguchi et al [6]. Immuno- the receptor density in these cells is much higher (up to
20-fold) than indicated by saturation analysis. Interest-precipitation studies of membrane preparations of meta-
bolically labeled CHO cells stably expressing the ingly, positive signals of transfected cells were more in-
Andersen-Beckh et al: Expression of V2 receptor in MDCK cells524
Fig. 5. Localization of c-myc–tagged wild-type V2 receptor in the subdomains of the plasma membrane of confluent Madin-Darby canine kidney
(MDCK) II clones. MDCK II clones were grown to confluency on different supports. Cells were fixed and processed with anti–c-myc antibody
for laser scanning microscopy. Shown are horizontal planes (xy-scan) of cells (upper panel) and vertical planes (z-scans) calculated at the indicated
lines from 260 sections (lower panel). Abbreviations are: ap, apical surface; bl, basal surface. (A) N-tagged V2 receptor (940,000 sites/cell), filter
support, cells not permeabilized. (B) N-tagged V2 receptor (940,000 sites/cell), glass cover slip, cells permeabilized. (C) C-tagged V2 receptor
(431,000 sites/cell), glass cover slip, cells permeabilized. The extent of the lateral staining corresponds to the cell height. A, 12 mm high; B and C,
6 mm high.
tense for permeabilized than for unpermeabilized cells. method, the lateral membranes of MDCK II clones were
intensively stained and the apical membrane very faintly,The less intense signals obtained with unpermeabilized
cells support the suggestion that the N-terminally tagged, suggesting a predominantly lateral expression of the V2
receptor (Figs. 4 and 5). In permeabilized MDCK IIglycosylated V2 receptors are less efficiently recognized
by the anti–c-myc antibody than are the intracellularly clones, the membrane staining was clearly dominant over
the intracellular signals, suggesting, in contrast tolocated, immature V2 receptors (discussed earlier in this
article). In addition, the presence of strong intracellular COS.M6 cells, the presence of only a small number of
intracellularly retained receptors. Thus, MDCK clonessignals in permeabilized cells indicated a large number
of intracellularly retained receptors [12]. In contrast, in combination with the TSA technique provide an excel-
lent experimental system for the analysis of such V2MDCK II clones stably expressing 150,000 N- or
C-terminally c-myc–tagged V2 receptors per cell yielded receptor mutants. In MDCK cells transfected with re-
combinant adenovirus harboring the wild-type V2 recep-no signal at either the cell surface or within the cell by
conventional immunocytochemical analysis. These dif- tor cDNA, conventional immunocytochemistry was suf-
ficient to detect V2 receptors. However, this approachficulties were overcome by applying the direct TSA tech-
nique. TSA was originally introduced to detect weak yielded a pattern of heavily stained intracellular mem-
branes, comparable to that found for transiently trans-signals in solid-phase immunoassays [28, 29] and later
adapted for immunohistochemistry at the light micro- fected COS.M6 cells [19]. The discrepancy between the
results obtained with stably transfected MDCK clonesscopic level [8, 30–32], the electron microscopic level
[33], and for in situ hybridization [reviewed in 34, 35]. (carrying probably only a single V2 receptor gene
copy) and those transfected with recombinant adenovi-The procedure for signal amplification has been named
differently by different authors and commercial suppli- rus (with a high copy number) may arise from the higher
level of expression in the adenoviral transfection, whichers: CARD [28], TSA (NEN, Ko¨ln, Germany), CSA
(Dako, Hamburg, Germany), ImmunoMax [31], and may cause intracellular accumulation of V2 receptors.
Madin-Darby canine kidney II clones showed an in-TAT [32]. During our study with the V2 receptor, the
use of TSA technique for the immunohistochemical lo- tense labeling of the lateral membranes and faint signals
at the apical membrane (Fig. 5). As apical membranecalization of two other G protein–coupled receptors was
published [36, 37]. We applied the TSA technique for the staining was also found (for both the N- or C-terminally
tagged V2 receptor), we verified the normal polarizationfirst time for the detection of a heptahelical membrane
protein in stably transfected MDCK II clones. With this of the cells by staining for ZO-1, a tight junction-associ-
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Fig. 7. Subconfluent Madin-Darby canine kidney (MDCK) II clones:
Localization of the c-myc–tagged wild-type V2 receptor. Subconfluent
MDCK II clones expressing N-tagged V2 receptor (940 000 sites/cell)
were grown on glass cover slips and were fixed and processed with
anti–c-myc antibody for epifluorescence microscopy. Symbols are: (*)
staining of the whole plasma membrane; (←) staining at the cell–cell
contact (Bar 10 mm).
subdomain (Fig. 5). Similar results were obtained for the
a2A adrenergic receptor expressed in MDCK cells [39].
This is in contrast to the staining of the basal membranes
observed in the rat renal collecting duct [2]. The reason
for the differences observed between cultured cells and
kidney tissue sections is unclear. One explanation might
be that cells cultured on Petri dishes in general display
more focal adhesion plaques than those cultured on an
authentic substratum or those in the collecting ducts in
Fig. 6. Distribution of ZO-1 in Madin-Darby canine kidney (MDCK) situ. The strong expression of focal adhesion plaquesII clones grown on glass cover slips. MDCK II clones expressing wild-
might interfere with receptor distribution into the basaltype V2 receptor (302,000 sites/cell) were fixed, permeabilized, and
processed with anti–ZO-1 antibody for laser scanning microscopy. Up- subdomain. Thus, the total receptor number in the basal
per panel, horizontal plane (xy-scan). Lower panel, vertical plane (xz-
membrane may lie under the detection limit. Alterna-scan). Bar 25 mm. Abbreviations are: ap, apical surface; bl, basal surface
at the top of the scan. tively, the access of the antibodies to the basal subdomain
may be reduced, although this is less likely, as experi-
ments with MDCK II clones grown on filter supports (in
which antibodies were applied from both the basal andated cytoplasmic protein [23]. ZO-1 was detected exclu-
apical sides) did not result in basal staining. The apicalsively in the apical region of the lateral membranes
membrane was faintly stained, independent of the cul-(Fig. 6), thus indicating a tight, polarized monolayer.
ture support used.These results were recently confirmed histocytochemi-
The NDI-causing L44P mutant V2 receptor was local-cally using V2 receptors fused at the C-terminus to the
ized only within the cell (Fig. 4D). No signal in the plasmagreen fluorescent protein and biochemically by biotinyla-
membrane was found. As the pattern of immunoreactiv-tion experiments [38]. When MDCK clones were not
ity resembles that obtained with rhodamine 6G chloride,confluent and thus not polarized, as evidenced by gaps
a fluorescent marker that enriches within mitochondriabetween the cells, the V2 receptor was expressed over the
and the endoplasmic reticulum [12], we assume the mu-whole cell (Fig. 7).
tant to be trapped within the endoplasmic reticulum.The existence of an apical signal in the confluent, po-
The lack of specific [3H]AVP binding to either intactlarized MDCK II clones is in agreement with immunocy-
MDCK II clones expressing the L44P mutant or to mem-tochemical data obtained from the rat renal collecting
brane preparations of these cells indicates misfolding asduct, in which V2 receptors were also observed to a
the cause of retention. This notion is supported by theminor extent at the apical surface [2]. Interestingly, in
our MDCK II clones, no signals were seen in the basal demonstration of only core-glycosylated L44P mutant
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